Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15185196 | 0.94 | TYR (0.31) | TYR | |
| SCHEMBL16926151 | 0.93 | TYR (0.31) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL15444497 | 0.87 | — | — | |
| SCHEMBL16433551 | 0.84 | MEN1 (0.30) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL16809953 | 0.84 | TYR (0.33) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL15279094 | 0.81 | HTR2A (0.39) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL14929995 | 0.80 | TYR (0.31) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL19196917 | 0.80 | TYR (0.46) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL12238347 | 0.78 | TYR (0.46) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL15727945 | 0.78 | TSHR (0.35) | TYRMEN1TP53CYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9835890-B2 | Liquid crystal display | MERCK PATENG GMBH (DE) | 2017-12-05 | — | — | US | disclosed |
| US-9428694-B2 | Liquid crystal medium | MERCK PATENT GMBH (DE) | 2016-08-30 | — | — | US | disclosed |
| US-20160159763-A1 | POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2016-06-09 | — | — | US | disclosed |
| US-20150205158-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2015-07-23 | — | — | US | disclosed |
| US-20140139786-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2014-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159763-A1 | POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | VCL, LPXN, LCP1 | TYR 1329/4885MEN1 1881/4885TP53 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.